Why is Thyrocare Tech. falling/rising?

As of 11-Sep, Thyrocare Technologies Ltd is experiencing a decline in its stock price, currently at 1,256.75, reflecting a decrease of 24.25 or 1.89%. The stock has underperformed its sector by 1.37% today and has been on a downward trend for the past five days, resulting in a total decline of 6.7%. The stock reached an intraday low of Rs 1246.8, indicating significant selling pressure. Despite a strong performance over the past year with a return of 47.34%, the company's recent growth metrics, such as a 56.61% increase in net profit and consistent positive results over six quarters, are overshadowed by concerns regarding its long-term growth potential and high valuation metrics, including a Price to Book Value of 12.1.
In the broader market context, the Sensex has shown a positive return of 1.03% over the past week, contrasting with Thyrocare's negative performance. This divergence highlights the stock's struggles relative to the overall market. Additionally, the stock's liquidity appears to be decreasing, with a significant drop in delivery volume, which may further contribute to its price decline. The presence of 100% of promoter shares being pledged adds to the risk profile, potentially exerting additional downward pressure in a falling market. Overall, while Thyrocare has demonstrated strong long-term performance, the current market sentiment and specific company risks are driving its recent price decline.